Tomaszewski, M.; Małkowska, P.; Sierawska, O.; Hrynkiewicz, R.; Mroczek, E.; Darocha, S.; Hymos, A.; Błaszczak, P.; Grywalska, E.; Niedźwiedzka-Rystwej, P.
CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension. Int. J. Mol. Sci. 2022, 23, 15910.
https://doi.org/10.3390/ijms232415910
AMA Style
Tomaszewski M, Małkowska P, Sierawska O, Hrynkiewicz R, Mroczek E, Darocha S, Hymos A, Błaszczak P, Grywalska E, Niedźwiedzka-Rystwej P.
CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension. International Journal of Molecular Sciences. 2022; 23(24):15910.
https://doi.org/10.3390/ijms232415910
Chicago/Turabian Style
Tomaszewski, Michał, Paulina Małkowska, Olga Sierawska, Rafał Hrynkiewicz, Ewa Mroczek, Szymon Darocha, Anna Hymos, Piotr Błaszczak, Ewelina Grywalska, and Paulina Niedźwiedzka-Rystwej.
2022. "CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension" International Journal of Molecular Sciences 23, no. 24: 15910.
https://doi.org/10.3390/ijms232415910
APA Style
Tomaszewski, M., Małkowska, P., Sierawska, O., Hrynkiewicz, R., Mroczek, E., Darocha, S., Hymos, A., Błaszczak, P., Grywalska, E., & Niedźwiedzka-Rystwej, P.
(2022). CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension. International Journal of Molecular Sciences, 23(24), 15910.
https://doi.org/10.3390/ijms232415910
